Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Spendlove

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Advances in Experimental Medicine and Biology|May 31, 2011
The role of CD97 in regulating adaptive T-cell responsesIan Spendlove, Ruhcha Sutavani
Expert Review of Vaccines|August 3, 2011
Using monoclonal antibodies to stimulate antitumor cellular immunityLindy G Durrant, Victoria A Pudney, Ian Spendlove
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancerPhil Rolland, Suha Deen, Ian Scott, et al.
Expert Opinion on Biological Therapy|April 14, 2010
Vaccines as early therapeutic interventions for cancer therapy: neutralising the immunosuppressive tumour environment and increasing T cell avidity may lead to improved responsesLindy G Durrant, Victoria Pudney, Ian Spendlove, et al.
Plos One|February 15, 2013
Therapeutic targeting of Lewis(y) and Lewis(b) with a novel monoclonal antibody 692/29Philip Noble, Ian Spendlove, Stephen Harding, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2006
Complement decay accelerating factor (DAF)/CD55 in cancerIan Spendlove, Judith M Ramage, Richard Bradley, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2006
The use of reverse immunology to identify HLA-A2 binding epitopes in Tie-2Judith M Ramage, Ian Spendlove, Robert Rees, et al.
International Journal of Cancer|May 19, 2005
Total loss of MHC class I is an independent indicator of good prognosis in breast cancerZahra Madjd, Ian Spendlove, Sarah E Pinder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Costimulation via CD55 on human CD4+ T cells mediated by CD97Melania Capasso, Lindy G Durrant, Martin Stacey, et al.
Endocrine-Related Cancer|March 31, 2007
The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive diseasePhil Rolland, Zahra Madjd, Lindy Durrant, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Advances in Experimental Medicine and Biology|May 31, 2011
The role of CD97 in regulating adaptive T-cell responsesIan Spendlove, Ruhcha Sutavani
Expert Review of Vaccines|August 3, 2011
Using monoclonal antibodies to stimulate antitumor cellular immunityLindy G Durrant, Victoria A Pudney, Ian Spendlove
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancerPhil Rolland, Suha Deen, Ian Scott, et al.
Expert Opinion on Biological Therapy|April 14, 2010
Vaccines as early therapeutic interventions for cancer therapy: neutralising the immunosuppressive tumour environment and increasing T cell avidity may lead to improved responsesLindy G Durrant, Victoria Pudney, Ian Spendlove, et al.
Plos One|February 15, 2013
Therapeutic targeting of Lewis(y) and Lewis(b) with a novel monoclonal antibody 692/29Philip Noble, Ian Spendlove, Stephen Harding, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2006
Complement decay accelerating factor (DAF)/CD55 in cancerIan Spendlove, Judith M Ramage, Richard Bradley, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2006
The use of reverse immunology to identify HLA-A2 binding epitopes in Tie-2Judith M Ramage, Ian Spendlove, Robert Rees, et al.
International Journal of Cancer|May 19, 2005
Total loss of MHC class I is an independent indicator of good prognosis in breast cancerZahra Madjd, Ian Spendlove, Sarah E Pinder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Costimulation via CD55 on human CD4+ T cells mediated by CD97Melania Capasso, Lindy G Durrant, Martin Stacey, et al.
Endocrine-Related Cancer|March 31, 2007
The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive diseasePhil Rolland, Zahra Madjd, Lindy Durrant, et al.
Pageof 5